{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:11:47Z","timestamp":1775070707623,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.pdpdt.2024.104028","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T16:41:50Z","timestamp":1709397710000},"page":"104028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Perifoveal retinal thickness changes after intravitreal aflibercept injection for choroidal neovascularization in age-related macular degeneration"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9893-7904","authenticated-orcid":false,"given":"Hakan","family":"Baybora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2024.104028_bib0001","first-page":"1897","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"64","author":"Martin","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0002","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"MARINA study group. Ranibizumab for neovascular age-related macular degeneration","volume":"55","author":"Rosenfeld","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0003","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"ANCHOR study group. Ranibizumab versus verteporfin for neovascular age related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0004","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000520171","article-title":"Development of macular atrophy in patients with wet age-related macular degeneration receiving anti-VEGF treatment","volume":"245","author":"Foss","year":"2022","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.pdpdt.2024.104028_bib0005","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaophthalmol.2014.1019","article-title":"Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials","volume":"132","author":"Ying","year":"2006","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0006","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1167\/iovs.11-8353","article-title":"Expression and role of VEGF in the adult retina pigment epithelium","volume":"52","author":"Ford","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0007","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1172\/JCI65157","article-title":"Targeted deletion of Vegfa in adult mice induced vision loss","volume":"122","author":"Kurihara","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0008","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","article-title":"Ranibizumab and bevacizumab for treatment of age-related macular degeneration: two-year results","volume":"119","author":"Martin","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2024.104028_bib0009","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10456-011-9249-6","article-title":"Binding and neutralization of vascularendothelial growth factor (VEGF) and related ligands by VEGF Trap. Ranibizumab and bevacizumab","volume":"15","author":"Papadopoulos","year":"2012","journal-title":"Angiogenesis"},{"key":"10.1016\/j.pdpdt.2024.104028_bib0010","first-page":"267","article-title":"Psychophysical evidence for rod vulnerability in age-related macular degeneration","volume":"41","author":"Owsley","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0011","first-page":"3278","article-title":"Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina","volume":"34","author":"Curcio","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0012","first-page":"1236","article-title":"Photoreceptor loss in age-related macular degeneration","volume":"37","author":"Curcio","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0013","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1568-1637(02)00007-7","article-title":"Photoreceptor degeneration and dysfunction in aging and age-related maculopathy","volume":"1","author":"Jackson","year":"2002","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0014","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1167\/iovs.03-0495","article-title":"Photopic and scotopic fine matrix mapping of retinal areas of increased fundus autofluorescence in patients with age-related maculopathy","volume":"45","author":"Scholl","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-004-1041-0","article-title":"The local cone and rod system function in early age-related macular degeneration","volume":"109","author":"Chen","year":"2004","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0016","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated for Age-related macular degeneration on OCT: classification of atrophy report 3","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2024.104028_bib0017","first-page":"394","article-title":"Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy (iRORA) in Age-related Macular Degeneration","volume":"127","author":"Guymer","year":"2020","journal-title":"CAM Report 4 Ophthalmol."},{"issue":"5","key":"10.1016\/j.pdpdt.2024.104028_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232353","article-title":"Complete RPE and outer retinal atrophy in patients receiving anti-VEGF treatment for neovascular age-related macular degeneration","volume":"15","author":"Eng","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.pdpdt.2024.104028_bib0019","article-title":"Outer retinal layers' thickness changes in relation to age and choroidal thickness in normal eyes","author":"Abdellatif","year":"2019","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0020","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1097\/IAE.0000000000001097","article-title":"Optical coherence tomography evidence on the correlation of choroidal thickness and age with neovascularized retinal layers in normal eyes","volume":"36","author":"Abdolrahimzade","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.pdpdt.2024.104028_bib0021","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1167\/iovs.13-11913","article-title":"Effect of age on individual retinal layer thickness in normal eyes as measured with spectral - domain optical coherence tomography","volume":"54","author":"Demirkaya","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0022","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ajo.2008.06.010","article-title":"Thickness profiles of retinal layers by optical Coherence tomography image segmentation","volume":"146","author":"Ba\u011fc\u0131","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0023","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0039-6257(00)00140-5","article-title":"The role of oxidative stress in the pathogenesis of age-related macular degeneration","volume":"45","author":"Beatty","year":"2000","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0024","first-page":"1290","article-title":"Age related variation in the hydraulic conductivity of Bruch's membrane","volume":"36","author":"Moore","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0025","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ophtha.2014.11.007","article-title":"Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trial","volume":"122","author":"Grunwald","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2024.104028_bib0026","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/bjophthalmol-2013-304019","article-title":"Different effects of intravitreally injected ranibizumab and aflibercept on retinal and choroidal tissues of monkey eyes","volume":"98","author":"Julien","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0027","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1097\/IAE.0000000000001765","article-title":"Macular atrophy and macular morphology in aflibercept treated neovascular age-related macular degeneration","volume":"8","author":"Kuroda","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.pdpdt.2024.104028_bib0028","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ophtha.2014.11.007","article-title":"Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trial","volume":"122","author":"Grunwald","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pdpdt.2024.104028_bib0029","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1097\/IAE.0000000000001059","article-title":"Progression of macular atrophy in patients with neovascular age-related macular degeneration undergoing antivascular endothelial growth factor therapy","volume":"36","author":"Abdelfettah","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.pdpdt.2024.104028_bib0030","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1167\/iovs.08-2691","article-title":"Quantitative subanalysis of intraretinal cystoid spaces and outer nuclear layer using optical coherence tomography in neovascular age-related macular degeneration","volume":"50","author":"Kashani","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0031","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.exer.2018.07.025","article-title":"Effects of bevacizumab, ranibizumab and aflibercept on phagocytic properties in human RPE cybrids with AMD versus normal mitochondria","volume":"177","author":"Vo","year":"2018","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.pdpdt.2024.104028_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2021.102582","article-title":"Long-term effect of intravitreal aflibercept treatment on choroidal vascular index in neovascular age-related macular degeneration","author":"Alis","year":"2021","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"5","key":"10.1016\/j.pdpdt.2024.104028_bib0033","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bjo.2007.134874","article-title":"Predicted biological activity of intravitreal VEGF Trap","volume":"92","author":"Stewart","year":"2008","journal-title":"Br. J. Ophthalmol."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157210002400067X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157210002400067X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T03:17:43Z","timestamp":1716952663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157210002400067X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":33,"alternative-id":["S157210002400067X"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2024.104028","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perifoveal retinal thickness changes after intravitreal aflibercept injection for choroidal neovascularization in age-related macular degeneration","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2024.104028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104028"}}